Turning Point Therapeutics Announces Proposed Public Offering of Common Stock

    NEXT STORY
    CorMedix Inc. to Present at the H.C. Wainwright 21st Annual Global Investment Conference
    PREV STORY
    Surface Oncology to Present at the Baird 2019 Global Healthcare Conference
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Interpace Diagnostics Group Reports First Quarter 2018 Financial Results, Business Progress and Recent Accomplishments

    Revenue Grew 39% Over the Prior Year’s Quarter and 10% Over the Prior Period ...

    author_avatar
    NASDAQ Market News

    Phase III data show Roche’s Port Delivery System with ranibizumab enabled over 98% of patients to go six months between treatments for neovascular age-related macular degeneration

    author_avatar
    NASDAQ Market News

    TiGenix strengthens US operations with senior appointments

    PRESS RELEASE TiGenix strengthens US operations with senior appointments - Dr. Gregory Gordon appointed ...

    author_avatar
    NASDAQ Market News